The goal of our preclinical anti-hepatitis virus drug development program is the cost-effective and expeditious evaluation of the efficacy, toxicity, range and mechanism of action of your compound. The development of anti-hepatitis virus compounds is somewhat different than efforts to characterize many other antiviral agents due to the lack of appropriate model systems.
Anti-Hepatitis B Virus Evaluation
Anti-Hepatitis C Virus Evaluation
Contact Us:
Phone: 888-322-1166
Email: busdev@southernresearch.org